Biodesix

BDSXNasdaq United States Health Care Medical Specialities

Market cap

$247.951 M

$23.50 +6.33%

Close of 7 Aug 2026

Revenue

$88.5M

#2556 by revenue

Earnings

-$35.3M

Loss-making

Shares outstanding

10,551,118

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities — ranked by market cap

All 44 →

#31Fulgent GeneticsFLGT$526.6M
#32TriSalus Life SciencesTLSI$344.5M
#33BiodesixBDSX$248.0M
#34Accendra HealthACH$214.4M
#35ExagenXGN$166.4M

Where these numbers come from

Share counts and financials for Biodesix are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.